Valerie D. Riddle
Direttore/Membro del Consiglio presso University of South Florida Foundation, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Gordon Gillette | M | 63 |
University of South Florida Foundation, Inc.
University of South Florida
| 7 anni |
| Darryl Michael Burman | M | 66 |
University of South Florida Foundation, Inc.
University of South Florida
| 5 anni |
| Joel Scott Chitwood | M | 54 |
University of South Florida Foundation, Inc.
| - |
| Leslie M. Muma | M | 79 |
University of South Florida Foundation, Inc.
| - |
| Jan E. Smith | M | 84 |
University of South Florida Foundation, Inc.
| - |
| H. William Habermeyer | M | 82 |
University of South Florida Foundation, Inc.
| - |
| William Tod Leiweke | M | 64 |
University of South Florida Foundation, Inc.
| 12 anni |
| Mark E. Fernandez | M | - |
University of South Florida Foundation, Inc.
| - |
| Merit L. Greaves | F | - |
University of South Florida Foundation, Inc.
| - |
| Brian Keenan | M | - |
University of South Florida Foundation, Inc.
| - |
| Jose E. Valiente | M | - |
University of South Florida Foundation, Inc.
| 12 anni |
| Debbie Sembler | F | - |
University of South Florida Foundation, Inc.
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Derace L. Schaffer | M | 76 |
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 2 anni |
| Mustafa Sagun | M | 58 |
University of South Florida
| 5 anni |
| Robert J. Troell | M | - |
University of South Florida
| 8 anni |
| Rick D. Hangartner | M | - |
University of South Florida
| 6 anni |
| Jae-Chul Yoon | M | 75 |
University of South Florida
| 5 anni |
| James DeMesa | M | 66 |
University of South Florida
| 6 anni |
| Bonnie Baker | F | - |
University of South Florida
| 4 anni |
| Dean Head | M | - |
University of South Florida
| 4 anni |
| Felice C. Wagner | F | - |
University of South Florida
| 4 anni |
| Jeannine Dunn | F | - |
University of South Florida
| 4 anni |
| Hillary R. Kasarjian | F | - |
University of South Florida
| 4 anni |
| Duke C. Intrapaiboon | M | 54 |
University of South Florida
| 4 anni |
| William A. Glauser | M | - |
University of South Florida
| 3 anni |
| Audra Moran | F | - |
University of South Florida
| 4 anni |
| Ron L. Tambasco | M | - |
University of South Florida
| 4 anni |
| Andre Rouviere | M | - |
University of South Florida
| 4 anni |
| Matt Crossett | M | - |
University of South Florida
| 4 anni |
| William J. Christ | M | - |
University of South Florida
| 3 anni |
| Sabrina Shattles | F | - |
University of South Florida
| 4 anni |
| Michael W. Perry | M | - |
University of South Florida
| 4 anni |
| Rick C. Brandt | M | - |
University of South Florida
| 4 anni |
| Albert McLelland | M | 66 |
University of South Florida
| 4 anni |
| Garrison Hasara | M | 54 |
University of South Florida
| 4 anni |
| Anthony Warren Welch | M | - |
University of South Florida
| 4 anni |
| Steven Perlstein | M | 55 |
University of South Florida
| 4 anni |
| David W. Saba | M | 62 |
University of South Florida
| 1 anni |
| Dan Krause | M | - |
University of South Florida
| 1 anni |
| Cynthia Lawrence | F | - |
University of South Florida
| 3 anni |
| Rachel Sapoznik | F | - |
University of South Florida
| 2 anni |
| Joe Volpe | M | - |
University of South Florida
| 3 anni |
| Amelia O. Pulliam | F | 52 |
University of South Florida
| 4 anni |
| Mark Royal Sorensen | M | - |
University of South Florida
| 3 anni |
| Robert Barry Harwood | M | 66 |
University of South Florida
| 4 anni |
| George Southworth | M | - |
University of South Florida
| 1 anni |
| James M. McGrew | M | - |
University of South Florida
| 4 anni |
| Craig Eckert | M | - |
University of South Florida
| 4 anni |
| Warrick A. Morgan | M | 59 |
University of South Florida
| 4 anni |
| Paul B. Thanasides | M | - |
University of South Florida
| 4 anni |
| John F. Panzarella | M | - |
University of South Florida
| 2 anni |
| Ann McKeel Ross | F | - |
University of South Florida
| 16 anni |
| Steve Athanassie | M | - |
University of South Florida
| 4 anni |
| Jeff Zysek | M | - |
University of South Florida
| 4 anni |
| Rohana binti Abdul Majid | F | 65 |
University of South Florida
| 4 anni |
| Edward Whelan | M | - |
University of South Florida
| 2 anni |
| Neil Chaudhry | M | - |
University of South Florida
| 1 anni |
| Ping Wai Lim | F | - |
University of South Florida
| 4 anni |
| Jim Maiz | M | - |
University of South Florida
| 3 anni |
| Ansbert Gadicke | M | 66 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 3 anni |
| Adam Stern | M | 60 |
University of South Florida
| 4 anni |
| Michael Novielli | M | 58 |
University of South Florida
| 4 anni |
| Mack Gill | M | 72 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 3 anni |
| Joseph McFadden | M | - |
University of South Florida
| 4 anni |
| Mike Allocco | M | - |
University of South Florida
| 4 anni |
| James P. Dietz | M | 58 |
University of South Florida
| 4 anni |
| Carol A. Smith | M | 72 |
University of South Florida
| 3 anni |
| Armando Anido | M | 66 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | 7 anni |
| Harald Hvideberg | M | 56 |
University of South Florida
| 4 anni |
| Kern Davis | M | 69 |
University of South Florida
| 3 anni |
| Laura Barton | F | 62 |
University of South Florida
| 4 anni |
| Arne Raabe | M | 54 |
University of South Florida
| 4 anni |
| Joseph Stach | M | 85 |
University of South Florida
| 3 anni |
| Brian F. Grimes | M | - |
University of South Florida
| 4 anni |
| Van C. Sayler | M | 69 |
University of South Florida
| 2 anni |
| Douglas Hannah | M | - |
University of South Florida
| 4 anni |
| Christopher J. Floyd | M | 61 |
University of South Florida
| 4 anni |
| Eric Wilwant | M | - |
University of South Florida
| 4 anni |
| Solomon Langermann | M | 64 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 3 anni |
| Jim Holder | M | 65 |
University of South Florida
| 4 anni |
| Christopher C. Camut | M | 61 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | - |
| Harry Newton | M | - |
University of South Florida
| 4 anni |
| Judson William Bibb | M | 67 |
University of South Florida
| 4 anni |
| Kenneth Mundy | M | - |
University of South Florida
| 4 anni |
| Paul T. Shea | M | - |
University of South Florida
| 4 anni |
| John W. Hadden | M | - |
University of South Florida
| 18 anni |
| Christopher A. Trina | M | 60 |
University of South Florida
| 4 anni |
| Mike Geldart | M | 60 |
University of South Florida
| 4 anni |
| Michael Myron Samoraj | M | - |
University of South Florida
| 4 anni |
| Lowe Morrison | M | - |
University of South Florida
| 6 anni |
| Steven St. Peter | M | 57 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 3 anni |
| Edward Solar | M | - |
University of South Florida
| 1 anni |
| Richard Schoenfeld | M | - |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 2 anni |
| Wayne Morges | M | 76 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 2 anni |
| Francesca M. Cook | F | 58 |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | 4 anni |
| Daniel Reininga | M | 66 |
University of South Florida
| 2 anni |
| Fredrick Hagan | M | - |
University of South Florida
| 4 anni |
| Alan M. Grunspan | M | 64 |
University of South Florida
| 4 anni |
| Kimberly Ross | F | 58 |
University of South Florida
| 4 anni |
| Andrea Colender | F | - |
University of South Florida
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Valerie D. Riddle
- Contatti personali
